共 312 条
[1]
Murray CJ(2013)Measuring the global burden of disease N Engl J Med 369 448-57
[2]
Lopez AD(2013)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 347-65
[3]
Vestbo J(2009)Investigating the natural history of lung function: facts, pitfalls, and opportunities Chest 135 1330-41
[4]
Hurd SS(2007)Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 775-89
[5]
Agusti AG(2011)Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2 Value Health 14 429-37
[6]
Jones PW(2009)Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis Pharmacotherapy 29 891-905
[7]
Vogelmeier C(2013)Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials Thorax 68 48-56
[8]
Anzueto A(2005)Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ 331 897-900
[9]
Kohansal R(2004)Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 30 3105-24
[10]
Soriano JB(1998)Meta-analysis of multitreatment studies Med Decis Making 18 37-43